Theratechnologies begins second phase II trial in sleep disorders; phase IIa results promising June 29, 2001
Preclinical results obtained by VaxGen suggest feasibility of broadly protective HIV vaccine June 29, 2001
AZ-242, a novel PPARalpha/PPARgamma activator for insulin resistance syndrome, type 2 diabetes June 29, 2001
RSS